ArticleInternational journal of molecular sciences2025
Correction: Mejía-García et al. Development and Validation of an Extracellular Matrix Gene Expression Signature for Prognostic Prediction in Patients with Uveal Melanoma.
Alejandro Mejía-García, Carlos A Orozco, Julius Herzog, Oscar Alarcón-Betancourth, Alexandra Meneses-Torres, Marcela Ramírez, Johanna González, Yina Zambrano, Alba Lucia Combita, Diego A Bonilla and 1 more
Abstract readPublished Erratum
In one paragraphArticle in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
11 authors.
Alejandro Mejía-GarcíaDepartment of Human Genetics, McGill University, Montreal, QC H3A 0G4, Canada.
Carlos A OrozcoCancer Biology Research Group, Instituto Nacional de Cancerología, Bogotá 110311, Colombia.
Julius HerzogDepartment of Biomedical and Health Sciences, University of Vermont, 106 Carrigan Drive, 302 Rowell, Burlington, VT 04505, USA.ORCID 0009-0002-2285-2549 Oscar Alarcón-BetancourthMaster Program in Epidemiology, Fundación Universitaria del Área Andina, Bogotá 110311, Colombia.
Alexandra Meneses-TorresMaster Program in Epidemiology, Fundación Universitaria del Área Andina, Bogotá 110311, Colombia.
Marcela RamírezMaster Program in Epidemiology, Fundación Universitaria del Área Andina, Bogotá 110311, Colombia.ORCID 0000-0003-2734-4981 Johanna GonzálezHealth and Sport Sciences Research Group, School of Health and Sport Sciences, Fundación Universitaria del Área Andina, Bogotá 110311, Colombia.ORCID 0000-0003-2106-4874 Yina ZambranoCancer Biology Research Group, Instituto Nacional de Cancerología, Bogotá 110311, Colombia.ORCID 0009-0000-5131-602X Alba Lucia CombitaTranslational Research Group in Oncology, Instituto Nacional de Cancerología, Bogotá 110311, Colombia.ORCID 0000-0001-6295-7316 Diego A BonillaResearch Division, Dynamical Business & Science Society, DBSS International SAS, Bogotá 110311, Colombia.ORCID 0000-0002-2634-1220 Seth FrietzeDepartment of Biomedical and Health Sciences, University of Vermont, 106 Carrigan Drive, 302 Rowell, Burlington, VT 04505, USA.ORCID 0000-0003-4058-3661 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
In the original publication [...].
Identifiers
PMID41465621
PMCPMC12733069
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390